Follow

A3P Biomedical AB

Nasdaq First North GM (Sweden)

A3P Biomedical is a Swedish company with a global mission – to radically improve precision in prostate cancer diagnostics and treatment.

Sector:
HEALTH CARE
 
News
No available news yet for A3P Biomedical AB
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Type
Ticker
ISIN
Market
SHARE
Nasdaq First North GM
Sweden (SE)
Details of share in A3P Biomedical AB with ticker
Status
Inactive
Amount of instruments
Currency
SEK
Type
Price
Pre-money
Time
Files
Listing
2021
Direct listing of A3P Biomedical AB on Nasdaq First North GM
People
David Rosén
CEO
Thomas Pollare
Chairman of the board
Cecilia Edström
Board member
Eugen Steiner
Board member
Henrik Grönberg
Board member
Martin Steinberg
Board member
Company Details
Sector
HEALTH CARE

Address
Husargatan 2-4
Zip code
752 37
City/district
Uppsala
Country
Sweden (SE)
Registration number
559252-9100
LEI code
9845003BE13F8F6CVF78
First trade date
Registration date
21 Apr 2020
Short name
A3P

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More